Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) encompasses chronic conditions, principally Crohn's disease and ulcerative colitis, in which the immune system mounts a dysregulated response against the gut, causing recurring inflammation and tissue damage. Genetic research has identified hundreds of susceptibility loci that shape how the intestinal immune system recognizes and tolerates the microbes it lives alongside, revealing that IBD arises from a complex interplay between inherited variation, microbial composition, and environmental triggers rather than any single cause. A central open question is why carrying particular risk variants leads to disease in some individuals but not others, and researchers are actively working to translate the catalogue of genetic signals into specific molecular mechanisms that could be targeted therapeutically. At the same time, rising incidence across newly industrialized regions is prompting investigation into how lifestyle and environmental shifts interact with genetic predisposition to drive what is increasingly a global health burden.
- Works
- 124,786
- Total citations
- 2,317,444
- Keywords
- Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative ColitisGeneticsImmunologyTherapies
Top papers in Inflammatory Bowel Disease
Ordered by total citation count.
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies↗ 6,015
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease↗ 5,606
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease↗ 5,031OA
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease↗ 4,905OA
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review↗ 4,836
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases↗ 4,693
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases↗ 4,618OA
- <i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients↗ 4,367OA
- Unravelling the pathogenesis of inflammatory bowel disease↗ 4,363
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial↗ 4,177
- Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis↗ 3,903OA
- Ulcerative colitis↗ 3,494OA
Active researchers
Top authors in this area, ranked by h-index.